U.S. Markets open in 6 hrs 23 mins

EGF Theramed Health Corp. (EVAHF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1499-0.0025 (-1.61%)
At close: 3:49PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1524
Open0.1220
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1220 - 0.1810
52 Week Range0.1220 - 5.0000
Volume33,299
Avg. Volume123,537
Market Cap150,423
Beta (5Y Monthly)2.46
PE Ratio (TTM)N/A
EPS (TTM)-0.0250
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    EGF THERAMED HEALTH Provides Update on Pharmadelic Labs and Green Parrot Labs

    VANCOUVER, BC / ACCESSWIRE / July 20, 2020 / EGF THERAMED HEALTH CORP.

  • ACCESSWIRE

    EGF Theramed Health Announces MOU with Greenfield Global Projects and Joint Venture Partner Green Parrot

    VANCOUVER, BC / ACCESSWIRE / July 9, 2020 / EGF THERAMED HEALTH CORP. (TMED.CN)(OTC PINK:EVAHF)(AUHP.F) (the "Company") announces that Global Green Parrot Laboratories Inc. ("GGP") has entered into a Memorandum of Understanding ("MOU") with Greenfield Global Projects Inc. ("Greenfield"). Greenfield is a private company with extensive cannabis related projects in Jamaica and corporate offices in Vancouver, B.C. Green Parrot Labs Corp. ("Green Parrot"), a joint venture partner in which the Company holds a 40% equity interest, holds a 70% equity interest in GGP.

  • ACCESSWIRE

    EGF Theramed Health Announces Leased Facilities for Pharmadelic Labs

    VANCOUVER, BC / ACCESSWIRE / June 22, 2020 / EGF THERAMED HEALTH CORP. (TMED.CN)(OTC PINK:EVAHF)(AUHP.F) (the "Company") announces that its joint venture partner, Pharmadelic Labs Corp. ("Pharmadelic Labs"), in which the Company holds a 30% equity interest, has secured additional lab facility space in order to expand its research and development of proprietary processes to help create pharmaceutical grade psilocybin-derived ingredients in a synthetic lab environment. Pharmadelic Labs has a leased space at a lab facility in Burnaby, British Columbia at a cost of $3,000 per month expiring May 1, 2021 and has begun plans for some minor retrofitting in advance of ordering/receiving DNA and certain lab equipment.